Track topics on Twitter Track topics that are important to you
GeneMax develops innovative immunotherapies in the fields of oncology and infectious disease. Our patented technology restores or increases antigen processing and antigen specific immune responses. GeneMax has demonstrated preclinical efficacy in animal models of lung cancer and melanoma as well as proof of principle for infectious disease pathogens.
GeneMax’s program also includes developing a therapeutic vaccine for diseases caused by the Human Papilloma Virus. This virus is known to cause cervical cancer, head and neck cancer, and respiratory papillomatosis. A second program is advancing to leverage GeneMax’s enabling technology for partnering with companies developing prophylactic vaccine products for infectious disease.
GeneMax develops innovative immunotherapies in the fields of oncology and infectious disease. Our patented technology restores or increases antigen processing and antigen specific immune responses. Ge...
We have published hundreds of GeneMax news stories on BioPortfolio along with dozens of GeneMax Clinical Trials and PubMed Articles about GeneMax for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GeneMax Companies in our database. You can also find out about relevant GeneMax Drugs and Medications on this site too.
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...